Stephen D. Simpson, CFA


Stock Analysis

  1. How Cool Is Ingersoll Rand?

    Might Ingersoll Rand's good news be seen as bad news for the broader market?
  2. Nucor Not In The Clear

    Another cautious outlook from the steel industry puts the economic recovery in question. ...
  3. Stryker Needs A Growth Resurfacing

    Stryker is a former growth darling struggling to regain its mojo, but the valuation ...
  4. VMWare's Vaporous Valuation

    The growth is great, but can any company grow enough to justify VMWare's valuation? ...
  5. Building a Portfolio Around Brazil's Building

    Brazil will be spending billions in preparations for the World Cup and Olympics, ...
  6. Bank Of New York Marking Time

    Custody is not an exciting business, but investors should not overlook this toll ...
  7. Bank Of America And Citigroup - Credit Now Giveth

    Investors need to look closely at bank earnings; not all beats are the same.
  8. Novartis On The Right Track

    With recent sales increases and a solid pipeline, Novartis deserves a spot on the ...
  9. Bye Bye NBTY

    This volatile supplements company goes away, and private equity is back.
  10. Investigators Send Home Health Care To The Hospital

    Investigations by the Senate and SEC have rattled this sector, but there is still ...
  11. A New Patent Problem For Smartphone Makers

    The company that secured a major settlement from RIMM is now targeting the new giants ...
  12. Ritchie Bros Feels The Hammer

    Ritchie Bros spooked the market with a mid-quarter update, but the growth strategy ...
  13. Will The EPA Crack Down On "Fracking"?

    The Gulf oil spill has pushed pollution concerns to the forefront, and helped to ...
  14. Iron-Clad Swaps

    The iron ore market is becoming increasingly open, but at the cost of more volatility. ...
  15. New EPA Rules Could Stir The Air

    New clean air regulations will burden the utility sector, but could create opportunities ...
  16. 7 Hot Medical Device Ideas

    These seven med-tech stocks are blazing a growth trail through their markets.
  17. Cancer Vaccines Continue To Show Promise

    Dendreon has put cancer vaccines back in the spotlight, but can they live up to their ...
  18. Time For Gilead To Open Its Wallet

    Gilead has carved out an exceptionally valuable niche, but should the company do ...
  19. Playing Big Pharma With CROs

    Investors looking to play the growth in R&D spending for human drugs should consider ...
  20. Is Another Wave Of Biotech M&A On The Way?

    If biotech companies are buying each other, should investors get in on the action? ...
  21. General Mills Treads Water

    General Mills is seeing good volume, but that's not enough to make it a great stock. ...
  22. The Next McDonald's

    Should investors take a nibble on any of the chains looking to unseat McDonald's? ...
  23. What Ails Amgen?

    Amgen is being treated like just another Big Pharma laggard, but analysis suggests ...
  24. Is Cheap Chinese Labor Over?

    "Cheap China" is increasingly becoming an anachronism. What does this mean for companies ...
  25. Profits In For-Profit Education

    For-profit education is here to stay, so which names should investors study up on? ...
  26. Muni-phobia

    There is a growing drumbeat that municipal bonds may be the next domino to fall in ...
  27. There Is Life After Death, At Least In Biotech

    Clinical failure is not the end of the story for all biotechs. How do some survive ...
  28. Can Investors Fatten Up On Weight Loss?

    Obesity is described as a multi-billion dollar crisis in North America, but how can ...
  29. FedEx Is Delivering The Recovery

    What do FedEx earnings say about our recovery?
  30. Lumber Does Not Bode Well For Housing

    Commodity lumber seems to be an uncanny forward indicator for home builder stocks, ...
  31. Covidien's Still Hungry

    Covidien is rapidly reconfiguring itself, but is management biting off too much at ...
  32. Can Investors Capture Gains In Carbon Capture?

    How can investors benefit from one of the more promising approaches to combating ...
  33. The Future of Stem Cells

    Stem cells get a lot of attention, but maybe not in the one area where they could ...
  34. SEA Ship-Shape Again

    Claymore's newly re-launched global shipping ETF gives investors an attractive option ...
  35. Sequencing Wars - The Third Generation

    Life sciences companies are gearing up for a battle that could decide hundreds of ...
  36. Satellite Phones Head Into Orbit

    Satellite phones are far from gone, as a $3 billion contract awarded last week indicates. ...
  37. Allscripts + Eclipsys = A Deal That Makes Sense

    Allscripts and Eclipsys complement each other well and should create a powerful force ...
  38. Ode To Joy Global

    Joy Global is a major equipment supplier leveraged to the commodity markets, but ...
  39. How Microsoft Lost Its Mojo

    Now that Apple has surpassed Microsoft, is there anything left in this software giant? ...
  40. Buffett's Take On The Credit Crisis

    In his testimony in front of Congress, Buffett goes easy on the ratings agencies. ...
  41. Intuitive Surgical - Are Robots To Be Trusted?

    Can Intuitive Surgical produce the growth necessary to validate the stock's lofty ...
  42. Covidien Shuffles The Deck

    Covidien made a surprising deal to get into peripheral vascular therapies - a business ...
  43. What ASCO Can Tell You About Biotechs

    ASCO is a major event for the pharmaceutical and biotech industry, and these stocks ...
  44. Medtronic - Life In The Crosshairs

    Medtronic will never be the growth stock it once was, but it is a high-quality medical-technology ...
  45. Apple Now King Of The Mountain

    Does Apple's ascent to the top of the market value chart presage more good returns, ...
  46. ASCO - A Big Deal For Biotechs

    ASCO is a major event for the pharmaceutical and biotech industry, and these stocks ...
  47. A Big Deal For Biotechs - ASCO

    ASCO is a major event for the pharmaceutical and biotech industry, and these stocks ...
  48. Auto Parts Could Rev Up Returns

    Can new products and new markets bring returns to a sector long seen as a dog?
  49. Great Dividend Payers In Medical Technology

    Dividend-paying stocks are not common in medical technology, but these four proven ...
  50. Unwrapping The Home-Improvement Big Boxes

    Putting the two giant home improvement stores head-to-head highlights some interesting ...
Trading Center